The Centers for Disease Control and Prevention (CDC) released its annual Sexually Transmitted Disease Surveillance Report, which reflects record highs in primary and secondary syphilis, gonorrhea and chlamydia.
Drugs & Pharmaceuticals
Welcome to the conclusion of our three part series discussing the science behind director Kathleen Gyllenhaal's latest documentary, IN UTERO. "To Avoid Adult Dysfunction Start 'IN UTERO'" took a deeper look at the health ramifications of toxic stress in prenatal life and its role in contributing to adult disease. Part I of our Q&A with Gyllenhaal emphasized health, Hollywood, how a story gets told and the parallels between funding for film and scientific research. In Part II, we explore her insights into motherhood and the impact of her recent film.
To kick off our new interview series Making the Rounds, we invited surgical oncologist Dr. Ogori Kalu to our New York office for a Facebook Live video streaming session to help educate the public on breast cancer prevention. Take a few minutes to learn about the discredited myths, and to watch the interesting round-table discussion with this Stanford-educated doctor.
Welcome to our three part series discussing the science behind director Kathleen Gyllenhaal's latest documentary, IN UTERO. "To Avoid Adult Dysfunction Start 'IN UTERO'" took a deeper look at the health ramifications of toxic stress in prenatal life and its role in contributing to adult disease. Part I of our Q&A with Gyllenhaal emphasizes health, Hollywood, how a story gets told and the parallels between funding for film and scientific research.
Welcome to our three part series discussing the science behind director Kathleen Gyllenhaal's latest documentary, IN UTERO. In Part II of the Q&A, we explore her insights into motherhood and the impact of her recent film.
http://acsh.org/news/2016/10/25/kathleen-gyllenhaal-health-meets-hollywood-qa-10351Welcome to our three part series discussing the science behind director Kathleen Gyllenhaal's latest documentary, IN UTERO. This article takes a deeper look at the health ramifications of toxic stress in prenatal life and its role in contributing to adult disease. Part I of our Q&A with Gyllenhaal emphasizes health, Hollywood, how a story gets told and the parallels between funding for film and scientific research. In the concluding Part II Q&A, we explore her insights into motherhood and the impact of her recent film.
A recent report stated that placebo treatments for pain can be effective even when patients know that it’s a placebo. On closer examination, however, this became somewhat less newsworthy. It has all the classic hallmarks of a fluke result that's partly the result of the statistics used, and partly over-interpretation of fairly modest results.
Earlier this month the FDA required that a "black box" warning — the most serious category — be placed on the "super hepatitis C drugs," such as Sovaldi and Harvoni. It doesn't make a lot of sense. An overreaction? That's what we believe. Here's why.
In the spirit of Breast Cancer awareness month and promoting women’s health, we are excited to have had Dr. Susan Wolf in our Manhattan office today for our Making the Rounds Facebook Live video streaming series. Dr. Wolf is a Reproductive Endocrinologist specializing in infertility and menopause. Additionally, she is a breast cancer and melanoma survivor - and, “borderline ovarian” which she personally addressed in our discussion. Watch the session now!
A new Harvard Medical School study says human physicians are "vastly superior" to computers when it comes to diagnosing conditions and illnesses. But is this result surprising? Not at all. Because, honestly, what other conclusion would we expect medical researchers to reach in evaluating the diagnostic performance of ... medical doctors and the medical profession?
Finally, a study where espousing the thought -- If you cared about my heart and well-being, then you wouldn’t stress me -- could be a win-win. Can anger trigger a heart attack? How about intense physical activity? Here's a closer look at heart health and heartbreak.
The concluding piece in this Brain Tumor series spotlights the expertise of Dr. Gregory Riggins. A professor of Neurosurgery and Oncology, and Director of the Brain Cancer Biology and Therapy Research Laboratory at Johns Hopkins, he will help us distinguish myth from reality.
Prescribing drugs is a valuable tool in our work, and we should not let medication prices be controlled by forces whose primary concern is the stockholder. Our role as physicians is to advocate for our patients; high drug prices lessen our ability to use the drugs our patients need. It is time for all of us to speak up.